Company overview

Qilu Pharmaceutical Co., Ltd.

USCC

91370000614073351Q

Id2

370000228034515

English Name

Qilu Pharmaceutical Co., Ltd.

Former names

山东齐鲁制药有限公司

Chinese Name

齐鲁制药有限公司

Entity type

Limited Liability Company (Legal Person Sole Ownership, Natural Person Invested or Controlled)

Authorized capital

¥60,000

Email

zcbgs@qilu-pharma.com

Phone

+8653183126666

Representative

鲍海忠 (Bao Hai Zhong)

Establishment date

21 August 1992

Country

China

Primary goods traded

  • 52.3% — Heterocyclic compounds (293299)
  • 37.1% — Inorganic or organic compounds of precious metals, n.e.c. (284390)
  • 8.4% — Organic compounds (294200)
  • 1.2% — Heterocyclic compounds (293329)
  • 0.9% — Medicaments (300320)
Main Trading Partners
PartnerTypeTotal ValuePercentage
PT Karunia Makmur Selarasbuyer$7,378,14039.83%
PT Bina San Primabuyer$416,7292.25%
PT Fonko International Pharmaceuticalsbuyer$278,2941.50%
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
Data SourceHS CodeDescriptionBuyerBuyer CountrySellerSeller Country
23 May 2022RU2932990000Other Heterocyclic Compounds Containing Only Oxygen Heteroatom(s): Other:Branch Of Lens Pharm Llc In BelgorodRUQilu Pharmaceutical Company Limited$1,884,580.00
20 June 2022RU2932990000Other Heterocyclic Compounds Containing Only Oxygen Heteroatom(s): Other:Veropharm LlcRUQilu Pharmaceutical Company Limited$1,841,790.00
8 September 2022RU2932990000Other Heterocyclic Compounds Containing Only Oxygen Heteroatom(s): Other: ChinaBranch Of Lens Pharm Llc In BelgorodRUQilu Pharmaceutical Company Limited$1,813,470.00
13 January 2023RU2932990000Other Heterocyclic Compounds Containing Only Oxygen Heteroatom(s): Other: ChinaBranch Of Lens Pharm Llc In BelgorodRUQilu Pharmaceutical Company Limited$1,622,310.00
25 April 2023RU2932990000Other Heterocyclic Compounds Containing Only Oxygen Heteroatom(s): Other: ChinaBranch Of Lens Pharm Llc In BelgorodRUQilu Pharmaceutical Company Limited$1,484,670.00
7 April 2022IN29420090Chemical : Oxaliplatin Eur (Qilu) (Trans-1- Diamino Cyclohexane Oxalatoplatinum)(list Item No.4;sr No.105Intas Pharmaceuticals LimitedINQilu Pharmaceutical Company Limited$539,701.82
3 December 2024ID28439000CarboplatinPT Karunia Makmur SelarasIDQilu Pharmaceutical Company Limited$482,885.13
20 September 2022IN29420090Chemical : Oxaliplatin Ph.Eur Qilu Trans-1-Diamino Cyclohexane Oxalatopatinum Listitem No:4sr No:105Intas Pharmaceuticals LimitedINQilu Pharmaceutical Company Limited$422,415.32
14 June 2024ID28439000CarboplatinPT Karunia Makmur SelarasIDQilu Pharmaceutical Company Limited$395,288.40
16 March 2020ID28439000CarboplatinPT Karunia Makmur SelarasIDQilu Pharmaceutical Company LimitedCN$284,325.00
0 of 20 row(s) selected.